Published in

Taylor and Francis Group, Emerging Microbes and Infections, 1(10), p. 2016-2029, 2021

DOI: 10.1080/22221751.2021.1994354

Links

Tools

Export citation

Search in Google Scholar

One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization

Journal article published in 2021 by Maggie Gu, Jonathan L. Torres, Yijia Li, Alex Van Ry, Jack Greenhouse, Shannon Wallace, Chi-I. Chiang, Laurent Pessaint, Abigail M. Jackson ORCID, Maciel Porto, Swagata Kar, Yuxing Li, Andrew B. Ward, Yimeng Wang ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO